Kura Oncology Other Current Liabilities

Kura Oncology (KURA) currently reports a other current liabilities of $55M as of June 2026. That compares with $100M in the prior-year period — down 45.5% year over year. Use the charts on this page to explore Kura Oncology's other current liabilities history and peer comparisons.

Kura Oncology's other current liabilities decreased from $100M to $55M — a 45.5% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Kura Oncology reported $55M in other current liabilities as of June 2026. That compares with $100M in the prior-year period — down 45.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other current liabilities of $55M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Kura Oncology, and consider following KURA for alerts when major investors trade the stock.

Kura Oncology is classified in the Healthcare sector. On other current liabilities, it currently shows $55M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing KURA with unrelated industries.